A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)
Clinical trial NCT02857426 · COMPLETED
Trial details
- NCT number
- NCT02857426
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-21
- Primary completion
- 2019-06-11
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.